Furosemide

Active Ingredient & Mechanism of Action

• Active Ingredient: Furosemide.
• Mechanism: Furosemide acts directly on the thick ascending limb of the loop of Henle in the kidneys:
  1. Inhibition of Electrolyte Reabsorption: It selectively blocks the $\text{Na}^+/\text{K}^+/2\text{Cl}^-$ co-transporter system, preventing the reabsorption of sodium, chloride, and water.
  2. Increased Diuresis: By retaining these electrolytes in the tubular fluid, it causes a rapid and marked increase in urine production (diuresis) and fluid excretion.
  3. Excretion of Other Ions: It also increases the excretion of potassium, magnesium, calcium, and hydrogen ions.

Dosage Forms & Available Strengths

• Oral Tablets: Standard strengths include 20 mg, 40 mg, and 80 mg.
• Oral Solution: 10 mg/mL and 40 mg/5 mL (commonly used for pediatric dosing or patients with swallowing difficulties).
• Injectable Solution (IV/IM): 10 mg/mL vials for intravenous or intramuscular administration in emergency, acute, or hospital settings.

Clinical Indications

• Edema Associated with Congestive Heart Failure: Reduces excess fluid accumulation in tissues and lungs (pulmonary edema).
• Hepatic Cirrhosis: Management of fluid overload and ascites (abdominal fluid buildup) associated with liver dysfunction.
• Renal Disease: Management of edema in patients with nephrotic syndrome or chronic kidney disease.
• Hypertension: Used alone or in combination with other antihypertensive agents for blood pressure control (typically when fluid retention is present or in patients with impaired renal function).
• Acute Pulmonary Edema: Rapid relief of acute fluid accumulation in the lungs via intravenous administration.

Key Pharmacokinetics

• Onset of Action: Oral administration yields rapid diuresis within 30 to 60 minutes, peaking at around 1 to 2 hours. Intravenous administration acts within 5 minutes, peaking at 20 to 30 minutes.
• Duration of Action: Short duration of action—approximately 6 to 8 hours for oral doses and 2 hours for intravenous administration.
• Elimination: Extensively bound to plasma proteins; cleared through both renal excretion (mostly unchanged) and hepatic clearance.

Administration Guidelines

• Oral Dosage: Administered once or twice daily. It is best taken in the morning (and early afternoon if twice daily) to prevent nighttime urination from disrupting sleep.
• Food Effect: Food can slightly decrease oral absorption, so taking it on an empty stomach or with a consistent meal schedule is recommended.

Safety Profile & Considerations

• Common Side Effects: Frequent urination, dehydration, dizziness, orthostatic hypotension (drop in blood pressure upon standing), headache, and electrolyte imbalances.
• Electrolyte & Metabolic Disturbances: Risk of hypokalemia (low potassium), hyponatremia (low sodium), hypomagnesemia, hypocalcemia, and hyperuricemia (elevated uric acid, which can trigger gout).
• Ototoxicity: High doses, rapid intravenous administration, or co-administration with other ototoxic drugs can cause transient or permanent hearing impairment and tinnitus.
• Contraindications: Anuria (inability to produce urine) and severe, uncorrected electrolyte depletion or hepatic coma.
• Key Drug Interactions:
  • Digoxin: Hypokalemia induced by furosemide significantly increases the risk of digitalis toxicity and cardiac arrhythmias.
  • Ototoxic Drugs (e.g., Aminoglycoside Antibiotics): Increased risk of severe hearing loss.
  • Nephrotoxic Drugs (e.g., NSAIDs, Radiocontrast Media): NSAIDs reduce diuretic efficacy and increase the risk of acute kidney injury.
  • Lithium: Decreases renal lithium clearance, leading to high risks of lithium toxicity.

Note: Furosemide is a potent, prescription-only medication. Dose adjustments and routine monitoring of fluid status, kidney function, and blood electrolyte levels must be conducted under the supervision of a licensed healthcare professional.